[Rectal micropolyps after total colectomy in familial polyposis. Efficacy of sulindac].

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Gastroentérologie Clinique et Biologique

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 2158470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulindac for polyposis of the colon.

  1989cited by this paper
• Regression of rectal adenomas after colectomy and ileorectal anastomosis for familial adenomatous polyposis

  1988cited by this paper
• [Efficacy of sulindac in the treatment of rectocolic polyposis].

  1986cited by this paper
• Sulindac treatment for familial polyposis coli.

  1985cited by this paper
• Nonsteroid antiinflammatory drugs and tamoxifen for desmoid tumors and carcinoma of the stomach

  1983cited by this paper
• The Occurrence of Carcinoma of the Rectum Following lleoproctostomy for Familial Polyposis

  1983cited by this paper
• Sulindac for polyposis of the colon

  1983cited by this paper
• Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor.

  1981cited by this paper
• Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine.

  1981cited by this paper
• Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment.

  1981cited by this paper
• Calcium and microtubule dependence for increased ornithine decarboxylase activity stimulated by beta-adrenergic agonists, dibutyryl cyclic AMP, or serum in a rat astrocytoma cell line.

  1980cited by this paper
• Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids.

  1980cited by this paper
• Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.

  1980cited by this paper
• Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle.

  1979cited by this paper
• The regulation of ornithine decarboxylase activity in intact normal and transformed cells maintained with a minimal salts/glucose medium.

  1979cited by this paper
• Arrest of cultured cells in the G1 phase of the cell cycle by indomethacin.

  1979cited by this paper
• Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase

  1978cited by this paper
• Polyamine biosynthesis and accumulation during the G1 to S phase transition

  1977cited by this paper
• Identification of the biologically active form of sulindac.

  1977cited by this paper
• The disposition of sulindac

  1977cited by this paper
• Antiproliferative activity of anti-inflammatory drugs in two mammalian cell culture lines.

  1977cited by this paper
• Studies on the regulation of ornithine decarboxylase activity by the microtubules: the effect of colchicine and vinblastine.

  1976cited by this paper
• Changes in L-ornithine decarboxylase activity during the cell cycle.

  1976cited by this paper
• The Inhibition by Aspirin and Indomethacin of Osteolytic Tumour Deposits and Hypercalcaemia in Rats with Walker Tumour, and its Possible Application to Human Breast Cancer

  1973cited by this paper
• Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man.

  1973cited by this paper
• Ornithine decarboxylase activity in synchronously growing Don C cells.

  1972cited by this paper
• Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

  1971cited by this paper
• Surgical management of multiple polyposis. The problem of cancer in the retained bowel segment.

  1970cited by this paper
• Intestinal bacterial flora after total and partial colon resection

  1970cited by this paper
• Spontaneous disappearance of rectal polyps following subtotal colectomy and ileoproctostomy for polyposis of the colon.

  1962cited by this paper
• Postcolectomy regression of adenomatous polyps of the rectum.

  1959cited by this paper
• Etiologic Factors in Polyposis and Carcinoma of the Colon

  1959cited by this paper
• Polyposis of the Colon

  1956cited by this paper

• Chemoprevention in hereditary digestive neoplasia: A comprehensive review

  2023cites this paper
• Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.

  2005cites this paper
• Colorectal cancer chemoprevention--an overview of the science.

  2004cites this paper
• Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention.

  2003cites this paper
• Chemopreventive Strategies Using NSAIDs and COX-2 Inhibitors

  2003cites this paper
• Epidemiology of Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer

  2003cites this paper
• Cancer and the Cyclo-Oxygenase Enzyme

  2003cites this paper
• Use of NSAIDs for the Chemoprevention of Colorectal Cancer

  2003cites this paper
• Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials.

  2003cites this paper
• The role of cyclooxygenase inhibitors in cancer prevention.

  2002cites this paper
• [Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].

  2001cites this paper
• Long‐term treatment with sulindac in familial adenomatous polyposis: Is there an actual efficacy in prevention of rectal cancer?

  2000cites this paper
• Chemoprevention in hereditary colorectal cancer syndromes

  1999cites this paper
• [Role of suindac in the treatment of familial adenomatous polyposis coli].

  1999cites this paper
• Chemoprevention in hereditary colorectal cancer syndromes

  1999cites this paper
• Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp

  1998cites this paper
• [Do aspirin or nonsteroidal anti-inflammatory drugs decrease the risk of colorectal cancer?].

  1998cites this paper
• [Diet and nonsteroidal anti-inflammatory drugs: role in prevention of colorectal cancer].

  1998cites this paper
• Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp.

  1998cites this paper
• [Aspirin, non-steroidal anti-inflammatory agents and colonic carcinogenesis].

  1997cites this paper
• Effects of sulindac on sporadic colorectal adenomatous polyps.

  1997cites this paper
• Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis

  1997cites this paper
• Discouraging colonic polyps.

  1997cites this paper
• NSAID-induced polyp regression in familial adenomatous polyposis patients.

  1996cites this paper
• The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.

  1995cites this paper
• Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment

  1995cites this paper
• Effect of sulindac on sporadic colonic polyps.

  1995cites this paper
• Clinical development plan: sulindac.

  1994cites this paper
• Sulindac in familial adenomatous polyposis.

  1994cites this paper
• Sulindac and polyp regression

  1994cites this paper
• Familial adenomatous polyposis

  1994cites this paper
• Cancer chemoprevention: principles and prospects.

  1993cites this paper
• NSAID effect on sporadic colon polyps.

  1993cites this paper
• The NSAID sulindac reverses rectal adenomas in colectomized patients with familial adenomatous polyposis: clinical results of a dose-finding study on rectal sulindac administration

  1993cites this paper
• The natural history of intraepithelial neoplasia: Relevance to the search for intermediate endpoint biomarkers

  1992cites this paper
• Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy.

  1992cites this paper
• Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers.

  1991cites this paper
• Sulindac causes regression of rectal polyps in familial adenomatous polyposis.

  1991cites this paper